EchoGo Pro vs AVIEW Lung Nodule CAD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

EchoGo Pro

by Ultromics

AVIEW Lung Nodule CAD

by Coreline Soft

AI Verdict

Tool A (EchoGo Pro) is specifically designed for the diagnosis of coronary artery disease through AI-powered stress echocardiography analysis. Tool B (AVIEW Lung Nodule CAD) primarily focuses on detecting and analyzing pulmonary nodules on chest CT scans, while also providing coronary artery calcification scoring. Although both tools offer AI-driven insights within cardiology and radiology, they utilize different imaging modalities and address distinct primary diagnostic objectives.

Choose EchoGo Pro if…

Choose EchoGo Pro if your cardiology department needs to significantly improve the efficiency and accuracy of stress echocardiography analysis for diagnosing coronary artery disease. This cloud-based, AI-powered solution provides near-instant, automated reports, making it ideal for high-volume settings requiring rapid and precise diagnostic support without extensive software installation.

View EchoGo Pro →

Choose AVIEW Lung Nodule CAD if…

Choose AVIEW Lung Nodule CAD if your radiology practice requires a comprehensive AI solution for analyzing chest CT scans, particularly for lung cancer screening and follow-up. This tool excels at detecting, classifying, and quantifying pulmonary nodules, while also offering simultaneous analysis of emphysema and coronary artery calcification, providing a holistic view for complex cases.

View AVIEW Lung Nodule CAD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	EchoGo Pro	AVIEW Lung Nodule CAD
Pricing	Contact vendor for pricing	Unknown
Deployment	Cloud-based	On-premises and cloud environment
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoGo Pro

EchoGo Pro emphasizes a cloud-based SaaS model that requires no software installation or extensive training, facilitating a low barrier to entry and seamless integration with existing clinical workflows. This focus on ease of deployment and use makes it highly accessible for clinicians.

Clinical Value

AVIEW Lung Nodule CAD

AVIEW Lung Nodule CAD offers a broader and more comprehensive 'Big 3' analysis, simultaneously detecting and analyzing lung nodules, emphysema, and coronary artery calcification from a single CT scan. This integrated approach provides a wider range of actionable clinical insights compared to EchoGo Pro's focused stress echocardiography analysis for CAD.

Pricing & Value

EchoGo Pro

While both tools require direct vendor contact for pricing, EchoGo Pro explicitly mentions the availability of reimbursement codes for related EchoGo products. This provides a clearer pathway for financial viability and demonstrates a stronger understanding of the economic value proposition for healthcare providers.

Enterprise Readiness

AVIEW Lung Nodule CAD

AVIEW Lung Nodule CAD offers greater deployment flexibility, supporting cloud, hybrid, local, and virtualized solutions, which caters to diverse enterprise IT infrastructures and data governance needs. Furthermore, its recent FDA clearance renewal highlights adherence to strengthened cybersecurity review criteria, a critical factor for enterprise adoption.

Innovation

AVIEW Lung Nodule CAD

AVIEW Lung Nodule CAD demonstrates greater innovation through its comprehensive 'Big 3' analysis, integrating detection and quantification of lung nodules, emphysema, and coronary artery calcification from a single CT scan. This multi-modal, holistic approach to screening represents a significant advancement in diagnostic capabilities.

Support & Docs

EchoGo Pro

Ultromics explicitly mentions the existence of an 'EchoGo Pro Clinician User Manual' and 'EchoGo Pro Operator Manual' in its FDA submission documents, indicating a formalized and comprehensive approach to user guidance for the software's operation. While Coreline Soft offers customer service, the specific mention of detailed user manuals for Tool A suggests more structured documentation for its use.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	EchoGo Pro	AVIEW Lung Nodule CAD
Name	EchoGo Pro	AVIEW Lung Nodule CAD
Company	Ultromics	Coreline Soft Co.
Primary Application	Automates stress echocardiography analysis to improve the diagnosis of coronary artery disease.	Assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, and offers comprehensive screening for lung cancer, COPD, and coronary artery calcification.
Key Analysis Focus	AI-powered automated echocardiogram analysis; automated identification of coronary artery disease (CAD).	AI-based pulmonary nodule detection (3-20 mm), nodule classification, 3D nodule size and volume quantification, quantitative emphysema analysis, Coronary Artery Calcification (CAC) scoring.
Automated Reporting	Provides near-instant, comprehensive reports.	Automatic report generation based on Lung-RADS classification.
Reimbursement Codes	Available for related EchoGo products (e.g., CPT 0932T for EchoGo Heart Failure, NTAP XXE2X19 for inpatient settings).	Not specified

Videos

Demos, reviews, and walkthroughs featuring EchoGo Pro and AVIEW Lung Nodule CAD.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and target specialties for each AI tool?

EchoGo Pro is an AI-powered cloud solution focused on automating stress echocardiography analysis to improve the diagnosis of coronary artery disease, primarily serving Cardiology. AVIEW Lung Nodule CAD is an AI-powered software that assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, offering comprehensive screening for lung cancer, COPD, and coronary artery calcification, targeting Cardiology, Pulmonology, and Radiology.

Which imaging modalities do these AI tools analyze?

EchoGo Pro analyzes stress echocardiography images. AVIEW Lung Nodule CAD analyzes chest CT scans.

What specific AI-powered analyses and reports do these tools provide?

EchoGo Pro provides AI-powered automated echocardiogram analysis for coronary artery disease identification and generates near-instant, comprehensive reports. AVIEW Lung Nodule CAD offers AI-based pulmonary nodule detection (3-20 mm), nodule classification (solid, part-solid, non-solid), 3D nodule size and volume quantification, automatic report generation based on Lung-RADS classification, nodule matching and volume doubling time (VDT) calculation, quantitative emphysema analysis, and coronary artery calcification (CAC) scoring.

Is there specific reimbursement information available for using these tools?

For EchoGo Pro, reimbursement codes are available for related EchoGo products, such as CPT 0932T for EchoGo Heart Failure and NTAP XXE2X19 for inpatient settings. For AVIEW Lung Nodule CAD, pricing details are not publicly disclosed, but pricing models for similar deep learning CAD systems often vary and may include per-case fees or one-time investments.

How do these tools integrate with existing clinical workflows?

EchoGo Pro is a vendor-neutral system compatible with any PACS and offers seamless integration with existing clinical workflows via DICOM and HL7. AVIEW Lung Nodule CAD complies with DICOM standards and can be linked with Picture Archiving and Communication Systems (PACS), providing a separate user interface for analysis, identification, storage, and transmission of quantified values related to lung nodules.